Bigfoot Biomedical Revenue and Competitors

Claim your profile

Location

#1860

Growjo Ranking

Estimated Revenue & Valuation

  • Bigfoot Biomedical's estimated annual revenue is currently $64.3M per year.(i)
  • Bigfoot Biomedical received $55.0M in venture funding in March 2018.
  • Bigfoot Biomedical's estimated revenue per employee is $313,750
  • Bigfoot Biomedical's total funding is $204.6M.

Employee Data

  • Bigfoot Biomedical has 205 Employees.(i)
  • Bigfoot Biomedical grew their employee count by 31% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M78-4%N/AN/A
#2
$3.5M34-8%N/AN/A
#3
$5.5M2283%N/AN/A
#4
$3.3M320%N/AN/A
#5
$5.8M23-28%N/AN/A
#6
$49.7M198-13%N/AN/A
#7
$9.8M39N/AN/AN/A
#8
$2.9M2875%N/AN/A
#9
$27.4M10911%N/AN/A
#10
$49.3M15728%$199.1MN/A

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. With an intense focus on ease of use, Bigfoot will optimize the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. The company's pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. Bigfoot will be the first company to deliver a monthly subscription-based service leveraging a smart, connected insulin dosing platform to meet the needs of a diverse population with insulin-requiring diabetes. Bigfoot's investigational system is comprised of best-in-class proprietary and licensed components holistically and securely integrated, leveraging intuitive design, machine learning, and a mobile app running on an off-the-shelf smartphone, all designed to keep glucose levels in an optimal range. The net result is a company that brings something unique to the table: a remarkable depth of knowledge and technical know-how combined with the personal motivation and direct patient experience necessary to really make a difference in this space. ---The MedTech Strategist, October 24, 2016

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

$204.6M

Total Funding

205

Number of Employees

$64.3M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bigfoot Biomedical News

2022-04-20 - Artificial Pancreas Devices Systems Market Size, Outlook And ...

Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed, Medtronic. This comprehensive Artificial Pancreas Devices...

2022-04-20 - Artificial Pancreas Device System (APDS) Market Size ...

Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed. This comprehensive Artificial Pancreas Device System (APDS)...

2022-04-17 - Artificial Pancreas Market Size, Outlook And Forecast ...

Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Pancreum, TypeZero Technologies, Beta Bionics, Medtronic Plc.

2021-06-24 - Bigfoot Unity™ Program Now Available in US, Revolutionizes How Clinicians Support Patients to Successfully Manage their Diabetes

Where does your enterprise stand on the AI adoption curve? Take our AI survey to find out. The program features first-of-its-kind technologies and a cloud-based platform that seamlessly connects clinics and health care providers to their Bigfoot Unity patients to enable continuous, proactive ca ...

2021-03-19 - Bigfoot Biomedical Secures Up To $57M in Debt and Equity Financing

Bigfoot Biomedical, a Milpitas, CA-based company dedicated to health outcomes for people with insulin-requiring diabetes, secured new debt and equity financing of up to $57m from Madryn Asset Management. The company intends to use the proceeds of the investment for commercialization of its Bigf ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$44.7M2145%N/A
#2
$33M2148%N/A
#3
$16.6M21629%N/A
#4
$37.2M23342%N/A
#5
$53.2M237N/AN/A

Bigfoot Biomedical Funding

DateAmountRoundLead InvestorsReference
2015-05-14$3.5MUndisclosedArticle
2015-07-29$3.8MUndisclosedArticle
2015-08-25$6.5MUndisclosedArticle
2016-01-29$2.4MUndisclosedArticle
2016-10-10$12.0MAMultipleArticle
2017-12-19$37.0MUndisclosedJanus Henderson InvestorsArticle
2018-03-29$55.0MBArticle